Amendment: SEC Form SC 13G/A filed by Insulet Corporation

10/7/24 11:37:08 AM ET

Medical/Dental Instruments

Health Care

Get the next $PODD alert in real time by email

SC 13G/A 1 filing.txt SCHEDULE 13G Amendment No.10 INSULET CORP COMMON STOCK Cusip #45784P101 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #45784P101 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 7,947,020 Item 6: 0 Item 7: 8,068,635 Item 8: 0 Item 9: 8,068,635 Item 11: 11.482% Item 12: HC Cusip #45784P101 Item 1: Reporting Person - Abigail P. Johnson Item 2: (a) [ ] (b) [ ] Item 4: United States of America Item 5: 0 Item 6: 0 Item 7: 8,068,635 Item 8: 0 Item 9: 8,068,635 Item 11: 11.482% Item 12: IN Item 1(a). Name of Issuer: INSULET CORP Item 1(b). Address of Issuer's Principal Executive Offices: 100 NAGOG PARK ACTON, MA 01720 USA Item 2(a). Name of Person Filing: FMR LLC Item 2(b). Address or Principal Business Office or, if None, Residence: 245 Summer Street, Boston, Massachusetts 02210 Item 2(c). Citizenship: Not applicable Item 2(d). Title of Class of Securities: COMMON STOCK Item 2(e). CUSIP Number: 45784P101 Item 3. This statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c) and the person filing, FMR LLC, is a parent holding company in accordance with Section 240.13d-1(b)(1)(ii)(G). (Note: See Exhibit A). Item 4. Ownership (a) Amount Beneficially Owned: 8,068,635 (b) Percent of Class: 11.482% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: Please see the responses to Items 5 and 6 on the cover page (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 8,068,635 (iv) shared power to dispose or to direct the disposition of: 0 Item 5. Ownership of Five Percent or Less of a Class. Not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person. One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the COMMON STOCK of INSULET CORP. No one other person's interest in the COMMON STOCK of INSULET CORP is more than five percent of the total outstanding COMMON STOCK. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. See attached Exhibit A. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. October 4, 2024 Date /s/ Stephanie J. Brown Signature Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. Exhibit A Pursuant to the instructions in Item 7 of Schedule 13G, the following table lists the identity and Item 3 classification, if applicable, of each relevant entity that beneficially owns shares of the security class being reported on this Schedule 13G. Entity ITEM 3 Classification FIAM LLC IA Fidelity Diversifying Solutions LLC IA Fidelity Institutional Asset Management Trust Company BK Fidelity Management & Research Company LLC * IA Fidelity Management Trust Company BK Strategic Advisers LLC IA * Entity beneficially owns 5% or greater of the outstanding shares of the security class being reported on this Schedule 13G. Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders' voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. This filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by FMR LLC, certain of its subsidiaries and affiliates, and other companies (collectively, the "FMR Reporters"). This filing does not reflect securities, if any, beneficially owned by certain other companies whose beneficial ownership of securities is disaggregated from that of the FMR Reporters in accordance with Securities and Exchange Commission Release No. 34-39538 (January 12, 1998). RULE 13d-1(k)(1) AGREEMENT The undersigned persons, on October 4, 2024, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the COMMON STOCK of INSULET CORP at September 30, 2024. FMR LLC By /s/ Stephanie J. Brown Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* Abigail P. Johnson By /s/ Stephanie J. Brown Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson** * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. ** This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 31, 2023, accession number: 0000315066-23-000038.

Get the next $PODD alert in real time by email

Recent Analyst Ratings for

$PODD

Date	Price Target	Rating	Analyst
1/27/2026	$294.00	Hold	TD Cowen
1/12/2026	$274.00	Overweight → Equal Weight	Barclays
12/16/2025	$370.00	Outperform	Evercore ISI
11/19/2025	$400.00	Neutral → Buy	UBS
10/21/2025	$370.00	Buy	Stifel
9/8/2025	$365.00	Outperform	Oppenheimer
6/16/2025	$365.00	Buy	Truist
5/30/2025	$380.00	Buy	Goldman

More analyst ratings

Amendment: SEC Form SC 13G/A filed by Insulet Corporation

10/7/24 11:37:08 AM ET

$PODD

Medical/Dental Instruments

Health Care

Get the next $PODD alert in real time by email

Recent Analyst Ratings for

$PODD

Date	Price Target	Rating	Analyst
1/27/2026	$294.00	Hold	TD Cowen
1/12/2026	$274.00	Overweight → Equal Weight	Barclays
12/16/2025	$370.00	Outperform	Evercore ISI
11/19/2025	$400.00	Neutral → Buy	UBS
10/21/2025	$370.00	Buy	Stifel
9/8/2025	$365.00	Outperform	Oppenheimer
6/16/2025	$365.00	Buy	Truist
5/30/2025	$380.00	Buy	Goldman

More analyst ratings

Amendment: SEC Form SC 13G/A filed by Insulet Corporation

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$PODD

Amendment: SEC Form SC 13G/A filed by Insulet Corporation

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$PODD

$PODD
Press Releases

Insulet to Announce First Quarter 2026 Financial Results on May 6, 2026

Insulet Appoints Mike Panos as Chief Commercial Officer

Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® 5 Pods in the U.S.

$PODD
Analyst Ratings

TD Cowen resumed coverage on Insulet with a new price target

Insulet downgraded by Barclays with a new price target

Evercore ISI initiated coverage on Insulet with a new price target

$PODD
Insider Purchases

Director Minogue Michael R bought $499,847 worth of shares (2,030 units at $246.23) (SEC Form 4)

President and CEO Mcevoy Ashley bought $1,029,205 worth of shares (4,300 units at $239.35), increasing direct ownership by 45% to 13,916 units (SEC Form 4)

Director Stonesifer Timothy C. bought $299,884 worth of shares (962 units at $311.73), increasing direct ownership by 27% to 4,591 units (SEC Form 4)

$PODD
Insider Trading

SEC Form 4 filed by Panos Michael

SEC Form 3 filed by new insider Panos Michael

SEC Form 4 filed by Huffines Robert Luther

$PODD
SEC Filings

Amendment: SEC Form SCHEDULE 13G/A filed by Insulet Corporation

Insulet Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

Insulet Corporation filed SEC Form 8-K: Leadership Update

$PODD
Leadership Updates

Insulet Appoints Mike Panos as Chief Commercial Officer

Insulet Announces Appointment of Robert L. Huffines to its Board of Directors

Insulet to Host Investor Day on November 20, 2025

$PODD
Financials

Insulet to Announce First Quarter 2026 Financial Results on May 6, 2026

Insulet Reports Fourth Quarter and Full Year 2025 Results

Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026

$PODD
Large Ownership Changes